ImageneBio (IMA) Current Assets (2020 - 2025)

ImageneBio has disclosed Current Assets across 6 years of filings, most recently posting $140.3 million for Q4 2025.

• Current Assets for Q4 2025 came in at $140.3 million, up 1025.18% year-over-year; the trailing twelve-month figure through Dec 2025 was $140.3 million (up 1025.18% YoY), and the FY2025 annual result was $140.3 million, up 1025.18% from the prior year.
• Current Assets came in at $140.3 million for Q4 2025 at ImageneBio, down from $147.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $283.2 million in Q1 2021 to a low of $12.5 million in Q4 2024.
• The 5-year median for Current Assets is $160.9 million (2023), against an average of $172.1 million.
• Across the five-year window, Current Assets tumbled 93.02% in 2024 and jumped 1025.18% in 2025, its largest moves.
• ImageneBio's Current Assets stood at $236.5 million in 2021, then sank by 32.35% to $160.0 million in 2022, then increased by 11.66% to $178.7 million in 2023, then sank by 93.02% to $12.5 million in 2024, then surged by 1025.18% to $140.3 million in 2025.
• The last three Current Assets figures came in at $140.3 million (Q4 2025), $147.5 million (Q3 2025), and $99.0 million (Q2 2025), per Business Quant data.